MTOR and carcinoma: Serial endometrial sampling studies should characterize temporal dynamics across the hyperplasia-to-carcinoma sequence—focusing on mTOR activation kinetics, STAT3 signaling, and adipokine fluctuations—as preventive readouts and to evaluate response to risk-reducing interventions (e.g., lifestyle modification), thereby informing the timing and intensity of surveillance.